Prognia
Drug Database
🇪🇺EU · EMARefusedATC: V03

Adlumiz(anamorelin hydrochloride)

Cachexia;Anorexia;Carcinoma, Non-Small-Cell Lung

Marketing Authorisation Holder: Helsinn Birex Pharmaceuticals Ltd.

INN: anamorelin

Indication

Treatment of anorexia, cachexia or unintended weight loss in adult patients with non-small cell lung cancer (NSCLC)

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Adlumiz — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.